MANUFACTURERS OF AN ALZHEIMER'S MEDICINE CLAIM A GREAT RESULT
Manufacturers of an Alzheimer's medicine claim that it delayed the disease's development in a late-stage trial
On Tuesday, the results of a long- awaited research showed that Eisai and Biogen's Alzheinmer's medicine.
Reduced cognitive loss in adults with early symptoms of the illness.
According to Eisai, 1,795 participants with early Alzheimer's disease
and amyloid beta in the brain were included in the new trial.
Over the course of 18 months, participants were given either a placebo or 10 milligrammes per kilogramme every two weeks.
According to the results of the trial, those who took the medicine had 27% less cognitive deterioration than those who took a placebo.
A WOMEN SURVIVES MOUNTAIN LION ATTACK IN UTAH